Compugen (CGEN) Net earnings per share growth forecast for next year

Symbol and logo of brand Compugen Ltd. (CGEN)

Compugen Ltd. (CGEN) is scaling its immuno-oncology portfolio through AI-driven target discovery and partnerships with industry behemoths. By comparing the history of forward EPS valuations on GURU.Markets, we see that 1.40 reflects the metric's baseline. The business remains isolated from economic cycles and inflation. The molecule licensing model protects the company from price wars, ensuring a steady inflow of capital.

CGEN - Compugen Limited Earnings growth forecast for next year over the range 07/04/2022 - 11/10/2026

Metric breakdowns and analytics for Compugen (CGEN)

- price and consensus price forecast:
Price Chart Compugen Ltd|CGEN - Consensus Target
- market capitalization details:
Market Value Compugen|CGEN - Real Price to Acquire Entire Company
- company book value details:
Accounting Value per Share Compugen|CGEN - Book Capitalization|Market Value to Book Value Ratio cgen.com|CGEN - Total Business Assets
- company liabilities and liquidity data:
Debt to Equity Compugen Ltd.|CGEN - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Compugen Ltd|CGEN - Company Total Indebtedness|Debt to Book Value Compugen|CGEN - Amount of Long-Term Liabilities|Company Short-Term Debts Compugen|Quick Ratio cgen.com
- earnings and market ratios statistics:
CGEN - Company Net Income|Expected Profit Compugen Ltd.|CGEN - Company Value to Net Income|Forward P/E Multiple Compugen Ltd|CGEN - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Compugen|CGEN - Profit before deduction of interest, taxes, depreciation and amortization|Net earnings per share for the last 12 months Compugen|CGEN - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth cgen.com|CGEN - Net earnings per share growth this year|Net earnings per share growth forecast for next year Compugen Ltd.
Analysis of all company metrics:Compugen Ltd.
Core merchandise of Compugen Limited

This indicator aggregates forecasts from hundreds of analysts, transforming fragmented data into a single vector of future profitability. It measures the mathematical expectation of the change in earnings per share, separating the fundamental trend from market noise. For Compugen Ltd. (CGEN), this metric reflects the market's valuation of their patent assets' efficiency and their successes in immuno-oncology. The trend of expected net earnings per share growth for the coming year visualizes the level of confidence in the biotech platform's management.

Direct competitors

Net earnings per share growth forecast for next year ImmunityBio Corp|Expected earnings per share growth for next year Immunocore Corp (IMCR)|Net earnings per share growth forecast for next year Janux Therapeutics (JANX)|Expected earnings per share growth for next year arcusbio.com RCUS|Zymeworks - Expected earnings per share growth for next year|Earnings growth forecast for next year Tango Therapeutics Inc TNGX|IOVA - Net earnings per share growth forecast for next year|IMTX (Immatics Biotechnologies) - Projected earnings per share growth rate for next year|Xencor, Inc. (XNCR) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year compasstherapeutics.com (CMPX)|Expected earnings per share growth for next year REPL|LYEL - Net earnings per one share growth forecast for next year|Expected earnings per share growth for next year IPHA (Innate Pharma, S.A.)|Projected earnings per share increase next year PYXS|Earnings growth forecast for next year IOBT (IO Biotech, Inc.)|Expected earnings per share trend next year STRO|MiNK Therapeutics - Earnings growth forecast for next year|Expected net earnings per share growth next year Werewolf Therapeutics|immixbio.com (IMMX) - Net earnings per share growth forecast for next year|ALX Oncology Holdings Inc. - Expected earnings per share trend next year|CUE (Cue Biopharma, Inc.) - Earnings growth forecast for next year|Earnings growth forecast for next year PDS Biotechnology Corp|Net earnings per share growth forecast for next year Sonnet BioTherapeutics (SONN)|MAIA: Net earnings per share change forecast for next year|Liminatus Pharma Corp - Expected earnings per share growth for next year|LAVA Therapeutics NV (LVTX) - Expected net earnings per share growth next year|NextCure, Inc. - Earnings growth forecast for next year|Leap Therapeutics, Inc. (LPTX) - Expected earnings per share growth for next year|intensitytherapeutics.com (INTS) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Sensei Biotherapeutics, Inc. (SNSE)|Net earnings per share growth forecast for next year Synthetic Biologics|Expected earnings per share growth for next year Gritstone Bio (GRTS)|Net earnings per share growth forecast for next year Kineta, Inc. (KA)|NEXI: Net earnings per share change forecast for next year|Turnstone Biologics Corp. - Expected earnings per share growth for next year|Earnings growth forecast for next year Vaccinex Inc. VCNX|Harpoon Tx - Earnings growth forecast for next year